Increased risk for depression after breast cancer: A nationwide population-based cohort study of associated factors in Denmark, 1998-2011

Journal of Clinical Oncology

Volumn 32, Issue 34, 2014, Pages 3831-3839

  Suppli, Nis P ^a,d   Johansen, Christoffer ^a,b   Christensen, Jane ^a   Kessing, Lars V ^c   Kroman, Niels ^b,d   Dalton, Susanne O ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Danish Breast Cancer Cooperative Group   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DENMARK; DEPRESSION; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HIGH RISK PATIENT; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MENTAL HOSPITAL; OUTCOME ASSESSMENT; PRESCRIPTION; RISK ASSESSMENT; RISK FACTOR; TUMOR VOLUME; VOCATION; BREAST NEOPLASMS; HOSPITALIZATION; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTPATIENT DEPARTMENT; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGY; REGISTER; TIME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; BREAST NEOPLASMS; DENMARK; DEPRESSION; DRUG PRESCRIPTIONS; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTPATIENT CLINICS, HOSPITAL; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84912106255     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.54.0419     Document Type: Article

References (35)

1. International Agency for Research on Cancer: GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact-sheets-population.aspx
2. Mitchell AJ, Chan M, Bhatti H, et al: Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. Lancet Oncol 12:160-174, 2011
3. Kessler RC: The costs of depression. Psychiatr Clin N Am 35:1-14, 2012
4. Pinquart M, Duberstein PR: Depression and cancer mortality: A meta-analysis. Psychol Med 40:1797-1810, 2010
5. Osborne RH, Elsworth GR, Hopper JL: Age-specific norms and determinants of anxiety and depression in 731 women with breast cancer recruited through a population-based cancer registry. Eur J Cancer 39:755-762, 2003
6. Bardwell WA, Natarajan L, Dimsdale JE, et al: Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol 24:2420-2427, 2006
7. Kim Sh, Son BH, Hwang SY, et al: Fatigue and depression in disease-free breast cancer survivors: Prevalence, correlates, and association with quality of life. J Pain Symptom Manage 25:644-655, 2008
8. Chen X, Zheng Y, Zheng W, et al: Prevalence of depression and its related factors among Chinese women with breast cancer. Acta Oncol 48:1128-1136, 2009
9. Azzone V, Frank RG, Pakes JR, et al: Behavioral health services for women who have breast cancer. J Clin Oncol 27:706-712, 2009
10. Hung YP, Liu CJ, Tsai CF, et al: Incidence and risk of mood disorders in patients with breast cancers in Taiwan: A nationwide population-based study. Psychooncology doi: 10.1002/pon.3277. [Epub ahead of print on March 6, 2013]
11. Thielen K, Nygaard E, Andersen I, et al: Misclassification and the use of register-based indicators for depression. Acta Psychiatr Scand 119:312-319, 2009
12. Moller S, Jensen MB, Ejlertsen B, et al: The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG): Its 30-years experience and future promise. Acta Oncol 47:506-524, 2008
13. Storm HH, Michelsen EV, Clemmensen IH, et al: The Danish Cancer Registry: History, content, quality and use. Dan Med Bull 44:535-539, 1997
14. Gaist D, Sorensen HT, Hallas J: The Danish prescription registries. Dan Med Bull 44:445-448, 1997
15. Munk-Jorgensen P, Mortensen PB: The Danish Psychiatric Central Register. Dan Med Bull 44:82-84, 1997
16. Bock C, Bukh JD, Vinberg M, et al: Validity of the diagnosis of a single depressive episode in a case register. Clin Pract Epidemiol Ment Health 5:4, 2009
17. Thygesen L: The register-based system of demographic and social statistics in Denmark. Stat J UN Econ Comm Eur 12:49-55, 1995
18. Andersen TF, Madsen M, Jorgensen J, et al: The Danish National Hospital Register: A valuable source of data for modern health sciences. Dan Med Bull 46:263-268, 1999
19. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
20. Hakulinen T: Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 38:933-942, 1982
21. Metcalfe KA, Semple J, Quan ML, et al: Changes in psychosocial functioning 1 year after mastectomy alone, delayed breast reconstruction, or immediate breast reconstruction. Ann Surg Oncol 19:233-241, 2012
22. Ganz PA, Kwan L, Stanton AL, et al: Physical and psychosocial recovery in the year after primary treatment of breast cancer. J Clin Oncol 29:1101-1109, 2011
23. Khan NF, Ward AM, Watson E, et al: Consulting and prescribing behaviour for anxiety and depression in long-term survivors of cancer in the UK. Eur J Cancer 46:3339-3344, 2010
24. de Bock GH, Musters RF, Bos HJ, et al: Psychotropic medication during endocrine treatment for breast cancer. Support Care Cancer 20:1533-1540, 2012
25. Sprague BL, Trentham-Dietz A, Nichols HB, et al: Change in lifestyle behaviors and medication use after a diagnosis of ductal carcinoma in situ. Breast Cancer Res Treat 124:487-495, 2010
26. Hjerl K, Andersen EW, Keiding N, et al: Increased incidence of affective disorders, anxiety disorders, and non-natural mortality in women after breast cancer diagnosis: A nation-wide cohort study in Denmark. Acta Psychiatr Scand 105:258-264, 2002
27. Dalton SO, Laursen TM, Ross L, et al: Risk for hospitalization with depression after a cancer diagnosis: A nationwide, population-based study of cancer patients in Denmark from 1973 to 2003. J Clin Oncol 27:1440-1445, 2009
28. Cronin-Fenton DP, Lash TL: Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes. Expert Rev Clin Pharmacol 4:363-377, 2011
29. Desmarais JE, Looper KJ: Interactions between tamoxifen and antidepressants via cytochrome P450 2D6. J Clin Psychiatry 70:1688-1697, 2009
30. Wang PS, Angermeyer M, Borges G, et al: Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 6:177-185, 2007
31. Olfson M, Marcus SC: National patterns in antidepressant medication treatment. Arch Gen Psychiatry 66:848-856, 2009
32. Abbing-Karahagopian V, Huerta C, Souverein PC, et al: Antidepressant prescribing in five European countries: Application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol: 2014
33. Charles J, Britt H, Fahridin S, et al: Mental health in general practice. Aust Fam Physician 36:200-201, 2007
34. Trifiro G, Tillati S, Spina E, et al: A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. Eur J Clin Pharmacol 69:227-236, 2013
35. Loosbrock DL, Tomlin ME, Robinson RL, et al: Appropriateness of prescribing practices for serotonergic antidepressants. Psychiatr Serv 53:179-184, 2002